The International
Federation of Pharmaceutical
Manufacturers Associations (IFPMA)
The mission of the
International Federation of Pharmaceutical Manufacturers
Associations (IFPMA) is to represent, through its member
associations, the international pharmaceutical and vaccine
industry engaged in the research and development and quality
manufacturing of innovative therapeutic and preventive medicines
and vaccines.
The IFPMA represents over 55
national industry associations from both developed and
developing countries. Companies in membership of the IFPMA are
the major global research-based pharmaceutical and vaccine
companies.
The IFPMA
strives to create a global environment that fosters innovation
in preventing and curing diseases, and regulation that
expedites approval of new chemical and biological treatments for
patients and assures the genuine quality of vaccines and
medicines.
In the current research and development
pipeline, industry has over 100 medicines and vaccines for
infectious diseases, many of which are particularly relevant to
the developing world, including HIV/AIDS, malaria, tuberculosis,
dengue, acute respiratory tract infections, diarrheal diseases
and several others.
For
more information about the IFPMA, visit its website at
http://web.archive.org/web/20001208231800/http://www.ifpma.org/
The IFPMA’s Role in
GAVI
The IFPMA is a full partner in GAVI. The vaccine-producing
members of the IFPMA have a long-standing legacy of working with
international public health agencies to ensure the enhancement
of health for children globally, through immunization.
Through the alliance, member partners will
address ways to accelerate the development and introduction of
new vaccines specifically needed by developing countries.
The vaccine industry members of the IFPMA
will, in cooperation with their GAVI partners, work to ensure
accessibility to vaccines for all the world’s children with a
particular focus on the poorest people and countries.
The specific vaccine industry partners
involved in GAVI are those that produce the greatest share of
the global vaccine supply. They are:
Aventis
Pasteur
SmithKline Beecham
American Home Products
Merck & Co., Inc.
Chiron Vaccines
BERNA Swiss Serum & Vaccine Institute Berne
(representing smaller vaccine producers)
|